Paper published in a journal (Scientific congresses and symposiums)
Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with metastatic or locally advanced solid tumors : assessment of safety and tolerability in a phase I, open-label expansion study
Kelly, Karen; Patel, Manish R.; Infante, Jeffrey R. et al.
2015In Journal of Clinical Oncology, 33 (suppl ; abstr 3044)
Peer Reviewed verified by ORBi
 

Files


Full Text
Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with metastatic ... - abstract.pdf
Publisher postprint (751.14 kB)
Request a copy
Annexes
Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with metastatic ... - poster.pdf
Publisher postprint (884.49 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
oncology
Disciplines :
Oncology
Author, co-author :
Kelly, Karen
Patel, Manish R.
Infante, Jeffrey R.
Iannotti, Nicholas
Nikolinakos, Petros
Leach, Joseph
Wang, Ding
Chandler, Jason Claud
JERUSALEM, Guy  ;  Centre Hospitalier Universitaire de Liège - CHU > Oncologie médicale
Gurtler, Jayne S.
Arkenau, Hendrik-Tobias
Speit, Isabell
von Heydebreck, Anja
CHIN, Kevin M.
Heery, Christopher Ryan
Gulley, James L.
More authors (6 more) Less
Language :
English
Title :
Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with metastatic or locally advanced solid tumors : assessment of safety and tolerability in a phase I, open-label expansion study
Publication date :
2015
Event name :
2015 ASCO Annual Meeting
Event place :
Chicago, United States
Event date :
May 29 - June 2 2015
Audience :
International
Journal title :
Journal of Clinical Oncology
ISSN :
0732-183X
eISSN :
1527-7755
Publisher :
American Society of Clinical Oncology, Alexandria, United States - Virginia
Volume :
33
Issue :
suppl ; abstr 3044
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 02 February 2016

Statistics


Number of views
120 (0 by ULiège)
Number of downloads
0 (0 by ULiège)

Bibliography


Similar publications



Contact ORBi